Low-dose IL-2 therapy in autoimmune diseases: mechanisms, clinical evidence, and future strategies for precision immune regulation

Zhidan Fan, Wenjing Zhu, Haiguo Yu

Open source

DOI
10.1007/s12016-026-09214-x
Published
2026-11-03
Container
Clinical Reviews in Allergy & Immunology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12016-026-09214-x,
  title = {Low-dose IL-2 therapy in autoimmune diseases: mechanisms, clinical evidence, and future strategies for precision immune regulation},
  author = {Zhidan Fan and Wenjing Zhu and Haiguo Yu},
  year = {2026},
  journal = {Clinical Reviews in Allergy \& Immunology},
  doi = {10.1007/s12016-026-09214-x},
  url = {https://doi.org/10.1007/s12016-026-09214-x}
}

RIS

TY  - JOUR
TI  - Low-dose IL-2 therapy in autoimmune diseases: mechanisms, clinical evidence, and future strategies for precision immune regulation
AU  - Zhidan Fan
AU  - Wenjing Zhu
AU  - Haiguo Yu
PY  - 2026
JO  - Clinical Reviews in Allergy & Immunology
DO  - 10.1007/s12016-026-09214-x
UR  - https://doi.org/10.1007/s12016-026-09214-x
ER  - 

APA

Fan, Z., Zhu, W., & Yu, H. (2026). Low-dose IL-2 therapy in autoimmune diseases: mechanisms, clinical evidence, and future strategies for precision immune regulation. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-026-09214-x

Source records